Skip to Content

Generic Gloperba Availability

Last updated on July 7, 2021.

Gloperba is a brand name of colchicine, approved by the FDA in the following formulation(s):

GLOPERBA (colchicine - solution;oral)

  • Manufacturer: AVION PHARMS
    Approval date: January 30, 2019
    Strength(s): 0.6MG/5ML [RLD]

Has a generic version of Gloperba been approved?

No. There is currently no therapeutically equivalent version of Gloperba available in the United States.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gloperba. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Colchicine drug-to-drug interactions
    Patent 10,226,423
    Issued: March 12, 2019
    Assignee(s): RxOMEG Therapeutics LLC

    The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided.

    Patent expiration dates:

    • December 20, 2037
      ✓ 
      Drug product
  • Patent 10,383,820

    Patent expiration dates:

    • November 22, 2036
      ✓ 
      Patent use: A METHOD OF PROPHYLACTIC TREATMENT OF GOUT FLARES IN ADULTS COMPRISES ADMINISTERING TO A PATIENT A LIQUID COLCHICINE ORAL SOLUTION
      ✓ 
      Drug product
  • Patent 10,383,821

    Patent expiration dates:

    • November 22, 2036
      ✓ 
      Drug product
  • Composition and method of use of colchicine oral liquid
    Patent 9,907,751
    Issued: March 6, 2018
    Assignee(s): RxOMEG Therapeutics LLC

    Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided.

    Patent expiration dates:

    • November 22, 2036
      ✓ 
      Drug product

Glossary

Term Definition
Drug Patent A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug Exclusivity Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.
RLD A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.